Download Non-steroidal Anti-inflammatory Drugs (NSAIDs) Presentation

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Pharmacokinetics wikipedia , lookup

Discovery and development of ACE inhibitors wikipedia , lookup

Discovery and development of proton pump inhibitors wikipedia , lookup

Pharmacognosy wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Drug interaction wikipedia , lookup

Aspirin wikipedia , lookup

Ofloxacin wikipedia , lookup

Psychopharmacology wikipedia , lookup

Bilastine wikipedia , lookup

Dydrogesterone wikipedia , lookup

Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup

Transcript
Non-Steroidal AntiInflammatory Drugs
ATPE 410
Chapter 6
Inflammatory Process
ƒ A normal, beneficial process that begins
immediately after injury to facilitate repair
and return the tissue to normal function
ƒ Initiated by stimulus including physical
trauma, radiation, chemicals, heat,
infection, and hypersensitivity
ƒ Causes the release of chemical
mediators
Chemical mediators
ƒ Definition:
ƒ are compounds released by one cell type that attach to the
receptor of a second cell type to affect the response by that
second cell
ƒ Contained in mast cells and basophils
ƒ Histamine- increases vascular permeability, increases blood
flow to injured area
ƒ Leukotrienes and prostaglandins- pain response, vascular
permeability, and chemotaxis
ƒ Phagocytes- neutrophils and macrophages remove debris
ƒ Serotonin- increases capillary blood flow and vascular
permeability
Chemical mediators
ƒ Have a relatively short half-life, so their site of
action is at or near the tissue that produces
them.
ƒ Known as “local hormones.”
ƒ Plasma protein systems are biochemical
sequences that produce proteins that have
specific functions in the inflammatory response
ƒ Kinin system
ƒ Bradykinin - Increases vascular permeability and pain
ƒ Complement system – also impacts inflammation
Arachidonic Acid
Metabolites
ƒ Arachidonic acid is an unsaturated fatty acid
that is the substrate for the production of
compounds (metabolites) that contribute to the
inflammatory response
ƒ Metabolites of arachidonic acid are also known
as eicosanoids
ƒ Arachidonic acid contributes to symptoms of
inflammation, including redness, swelling, and
pain
ƒ Phospholipase A2 catalyzes the intracellular
release of arachidonic acid from the
phospholipids
Arachidonic Acid
Metabolites
ƒ Follows one of two pathways:
ƒ cyclooxygenase (COX)
ƒ lipoxygenase (leukotriene)
ƒ Pathways lead to four eicosanoid mediators
ƒ
ƒ
ƒ
ƒ
prostaglandins (PGs)
prostacyclin (PGI2)
thromboxanes (TXs)
leukotrienes (LTs)
ƒ The COX pathway leads to the production of TX, PG,
and PGI2
ƒ Two forms of COX enzyme, known as isoforms
ƒ COX-1- produced in most tissues at a stable rate
ƒ COX-2- produced in the brain, female reproductive tract, blood vessel
walls, and kidneys
ƒ Production is also induced by tissue injury
Non-Steroidal AntiInflammatory Drugs
(NSAIDs)
ƒ Most frequently prescribed and frequently
used OTC drugs
ƒ Major mechanism of action is to
decrease PG production by inhibiting one
or both of the cyclooxygenase isoforms
(COX-1, COX-2)
ƒ COX-2 is enhanced in response to pain and
inflammation so NSAIDs primarily inhibit this
isoform rather than both COX-1 and COX-2
Therapeutic Uses of
NSAIDs
ƒ Treat both acute and chronic inflammation
ƒ A week or 2 of therapy is typically long enough to determine whether
the anti-inflammatory effect is sufficient
ƒ Treats inflammation associated with musculoskeletal disorders such
as osteoarthritis, rheumatoid arthritis, gout, tendonitis, sprains, and
strains
ƒ Reduces pain, swelling, stiffness, and increases mobility
ƒ Questionable if it decreases healing time to increase return to
activity
ƒ Selection of the NSAID, dosing, and duration impacts the potential for
improved healing rate
ƒ Use of other modalities simultaneously with NSAIDs helps decrease
inflammation
ƒ All NSAIDs have analgesic and antipyretic (fever reducing) activity
ƒ Aspirin and ibuprofen most commonly used to reduce fever
ƒ Acetaminophen (Tylenol)- not a NSAID but also reduces fever
Therapeutic Uses of
NSAIDs
ƒ Inhibit uterine synthesis of eicosanoids that contribute
to cramps and excessive bleeding in menstruation
ƒ COX-1 inhibitors have antiplatelet activity and thus
have and anticoagulant effect
ƒ Platelet aggregation stimulates activation of blood coagulation
that can lead to thromboembolism, myocardial infarction,
transient ischemic attack, or stroke
ƒ COX-1 produces TXA2, which stimulates platelet aggregation
ƒ COX-2 produces PGI2, which inhibits platelet aggregation
ƒ Aspirin differs from other NSAIDs because it is an irreversible
inhibitor of the COX enzymes
ƒ All other NSAIDs are reversal inhibitors and therefore less effective for
antiplatelet therapy
ƒ Low-dose aspirin (40-325 mg/day) is effective for antiplatelet therapy
Pharmacokinetics and
Dosage of NSAIDs
ƒ Absorption
ƒ All NSAIDs are absorbed rapidly from the gastrointestinal tract, and
thus almost all NSAIDs are available only as oral preparations
ƒ Gastrointestinal upset can occur, so it should be taken with food or
milk, or at least a glass of water
ƒ Enteric-coated aspirin can reduce stomach upset but it delays
absorption
ƒ Distribution
ƒ NSAIDs distribute into the central nervous system, in breast milk, and
across the placenta
ƒ Extensively bound to plasma protein (especially some COX-2
inhibitors)
ƒ Ibuprofen, fenoprofen, naproxen, and tolmetin are 99% bound to plasma protein
ƒ Metabolism and Excretion
ƒ Metabolized by the liver and excreted through urine
ƒ Both glomerular filtration and/or renal tubular excretion are used in
the kidneys to get NSAIDs and their metabolites into the renal tubule
Pharmacokinetics and
Dosage of NSAIDs
ƒ Aspirin Dosage
ƒ The antipyretic dose for aspirin and ibuprofen is similar to the
dose for relief of mild to moderate pain
ƒ Risk of Reye’s syndrome associated with the use of aspirin in
children with fever
ƒ NSAID Dosage
ƒ The anti-inflammatory and analgesic dosage for NSAIDs
varies between patients and the extent of their inflammation
ƒ Anti-inflammatory dosage is typically greater than analgesic
dosage
ƒ Toxicity
ƒ Symptoms include tinnitus, nausea, vomiting, hyperthermia,
sweating, disorientation
ƒ Outdated bottles of aspirin have an odor of vinegar (acetic
acid)
Adverse Effects of NSAIDs
ƒ Most common adverse effects are gastrointestinal
irritation, heartburn, nausea, gastrointestinal bleeding,
and gastric and duodenal ulcers
ƒ Side effects occur more commonly with aspirin than NSAIDs
ƒ Signs include indigestion, dark stools, nausea, vomiting, and
abdominal pain
ƒ Two mechanisms develop gastrointestinal adverse
effects
ƒ Direct local irritation when drug is in contact with gastric
mucosa
ƒ Systemic action of inhibiting COX
ƒ Avoiding irritation
ƒ Administer with milk, food, or antacids (except for coated
products)
ƒ Proton pump inhibitor- reduces the amount of acid pumped
into the stomach to decrease negative effects
Adverse Effects of NSAIDs
ƒ Hypersensitivity is another adverse effect
ƒ Symptoms begin within 3 hours of ingestion
ƒ Include rhinitis, bronchospasm, asthma attack
ƒ Liver and Renal toxicity (hepatoxicity)
ƒ Renal toxicity is more common than liver toxicity
ƒ Symptoms include nausea, fatigue, jaundice, right
upper quadrant abdominal pain, flu-like symptoms
ƒ Use caution when administering to those with
history of heart failure, hypertension, or kidney
disease
Drug Interactions with
NSAIDs
ƒ Aspirin must be used with caution with
Warfarin (Coumadin)
ƒ COX-2 inhibitors may also affect warfarin response
because of plasma protein binding or inhibition of
CYP450 enzyme metabolism
ƒ Acetaminophen does not have these anticoagulant
effects
ƒ NSAIDs diminish effect of antihypertensive
drugs
ƒ Includes diuretics, angiotensin-converting enzyme
inhibitors, B-blockers
NSAID Therapy Guidelines
ƒ The lowest dose for the shortest duration
of therapy that accomplishes the
therapeutic goal should be used
ƒ Most NSAIDs are not used in children,
however ibuprofen is an exception
Corticosteroids
ƒ The adrenal gland produces two types of
corticosteroids
ƒ Glucocorticoids – cortisol (hydrocortisone) is
primary
ƒ Mineralocorticoids – aldosterone is primary
Therapeutic Uses of
Corticosteroids
ƒ Major use is to suppress the immune and inflammatory
responses
ƒ Corticosteroids inhibit the activity of phospholipase A2 to
decrease both prostaglandin and leukotriene production
ƒ Reduces the swelling and pain associated with inflammation
ƒ Inhibit infiltration of phagocytes and lymphocytes at the site of
inflammation
ƒ Inhibit release of other chemical mediators that affect the inflammatory
and immune responses, like histamine and some cytokines
ƒ Also used to treat rheumatoid and gouty arthritis,
systemic lupus erythematosus, bronchial asthma,
inflammatory bowel disease, tendonitis, bursitis,
allergic reactions, and dermatologic diseases
Pharmacokinetics and
Dosage
ƒ Administration
ƒ Inhalation for asthma
ƒ Topical application for local, non-systemic effects
(dermatological)
ƒ Local and intramuscular injections
ƒ Oral – beneficial because they are usually almost
completely absorbed by the GI tract
ƒ Metabolism and Excretion
ƒ Liver metabolism
ƒ Urine excretion
Adverse Effects of
Corticosteroids
ƒ The amount of corticosteroid produced by the adrenal
gland is regulated through a feedback regulation
process by the amount of corticosteroid in the blood
ƒ Hypothalamic-Pituitary-Adrenal (HPA) axis
ƒ When corticosteroid level in the blood decreases, the hypothalamus
releases corticotrophin-releasing hormone (CRH) which signals the
anterior pituitary to release adrenocorticotropic hormone (ACTH),
which signals the adrenal gland to produce more corticosteroid (cortisol)
ƒ When corticosteroid level is sufficient, the adrenal gland signals the
hypothalamus and pituitary to stop releasing hormone
ƒ If adrenal suppression occurs and the dose of corticosteroid is
removed too quickly, the patient can experience various
symptoms including nausea, vomiting, anorexia, headache,
lethargy, fever, and muscle and joint pain
Drug Interactions with
Corticosteroids
ƒ Patients on NSAIDs have an increased
risk of peptic ulcers when corticosteroids
are added to therapy
Corticosteroid Therapy
Guidelines
ƒ Dosage
ƒ Short-term therapy is less than one week
ƒ As doses of prednisone increase above 5
mg/day, the dose is considered
supraphysiologic and capable of causing
adrenal suppression
ƒ Discontinued therapy should be tapered off
in patients with adrenal suppression to allow
the HPA axis to recover
Glucosamine
ƒ
ƒ
Classified as a dietary supplement
Use and Effects
ƒ Not analgesic or anti-inflammatory (does not affect COX pathway)
ƒ Aminomonosaccharide that is used to make glycosaminoglycans, components
of proteoglycans used to make cartilage
ƒ Used to stop or reverse the progression of osteoarthritis
ƒ Causes reduced restriction of active and passive movement, articular pain, and joint
tenderness and swelling
ƒ
Pharmacokinetics and Dosage
ƒ Absorbed orally
ƒ First pass effect reduces bioavailability to about ¼ the oral dose
ƒ Most common dosage is 500 mg three times a day in the form of glucosamine sulfate
ƒ Excreted by the kidneys
ƒ Also marketed as chondroitin sulfate, another glycosaminoglycan
ƒ Chondroitin is more expensive and possibly less effective than glucosamine
ƒ Adverse Effects
ƒ Gastrointestinal discomfort, headache, skin rash, itching
Topical Anti-Inflammatory
Products
ƒ Salicylate
ƒ Applied to site of strains, sprains, and muscle
soreness
ƒ Has not been shown to be more effective than oral
NSAIDs
ƒ Absorption
ƒ Penetrate directly into the skin
ƒ Rate is dependent on site of application and number of
applications
ƒ Amount absorbed is too low for systemic therapeutic purposes
ƒ Should be used with the same caution as other
NSAIDs in patients with risk factors like
hypersensitivity, renal disease, liver disease, and
alcohol use
Topical Anti-Inflammatory
Products
ƒ Counterirritants
ƒ Sometimes a component of anti-inflammatory/analgesic
products
ƒ Produce less severe pain by distracting patient with another
type of pain
ƒ Should not be applied to wounded, damaged, or open skin
ƒ Other Topical NSAIDs
ƒ Capsicum - inhibits Substance P, a neurotransmitter that is
involved with peripheral pain
ƒ Camphor and Menthol – relieve itching
ƒ Hydrocortisone – topical corticosteroid
ƒ All topical drugs, as with other drugs, can have a
placebo effect
Role of the Athletic
Trainer
ƒ Alter the dose and duration of the treatment according
to the therapeutic goal
ƒ Considerations
ƒ The benefits and risks must be weighed for each athlete
ƒ NSAIDs should be taken with food or milk, and especially
water, to reduce gastric upset
ƒ Only one NSAID should be used at a time
ƒ Recognize the long-term effects of NSAIDs
ƒ Recognize at-risk athletes who should not take NSAIDs
ƒ Inform athletes of all risks, dosage procedures, and symptoms
of adverse effects caused by NSAIDs